P-393 A real-world UK experience of Daratumumab, Velcade, Dexamethasone and Carfilzomib, Lenalidomide, Dexamethasone as second line therapies in the UK: a South East London retrospectiveDogan Yildiz, Arief Gunawan, Youssef Salam et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 0